Report cover image

Uveitis: Opportunity Assessment and Forecast

Publisher GlobalData
Published Mar 31, 2025
Length 74 Pages
SKU # GBDT19969566

Description

Uveitis: Opportunity Assessment and Forecast

Summary

This report covers the 7MM (US, 5EU, Japan) and provides an Excel-based forecast model for the uveitis market through 2033.
  • There will be an overall increase in the diagnosed prevalent cases of uveitis in the 7MM across the forecast period.
  • Across the 7MM, the mainstay treatment for uveitis involves the use of anti-inflammatory therapies.
  • Significant clinical unmet needs remain in the uveitis market.
  • The late-stage uveitis pipeline consists of six agents.
  • The uveitis market in the 7MM was valued at $522.5 million in 2023. The market is projected to grow at a CAGR of 10.9%, reaching $1.5 billion by 2033.
Scope
  • Overview of uveitis, including epidemiology, symptoms, diagnosis, and disease management.
  • Annualized uveitis therapeutics market revenue in 7MM (US, 5EU, and Japan), annual cost of therapy and treatment usage pattern in 2023 and forecast for 10 years to 2033.
  • Key topics covered include strategic competitor assessment, market characterization, unmet needs, clinical trial mapping and implications for the uveitis therapeutics market.
  • Pipeline analysis, comprehensive data assessing emerging trends and mechanisms of action under development for uveitis treatment. The most promising candidates in late-stage development are profiled.
  • Analysis of the current and future market competition in the 7MM uveitis therapeutics market. Insightful review of the key industry drivers, restraints, and challenges. Each trend is independently researched to provide a qualitative analysis of its implications.
Reasons to Buy
  • Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
  • Develop business strategies by understanding the trends shaping and driving the uveitis therapeutics market.
  • Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the uveitis therapeutics market in the future.
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
  • Identify emerging players with potentially strong product portfolios and create effective counterstrategies to gain a competitive advantage.
  • Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments, and strategic partnerships.
Please note: this is delivered as a Zip file.

Table of Contents

74 Pages
1. Preface
1.1. Contents
1.2. Abbreviations
1.3. Related Reports
2. Executive Summary
3. Disease Overview
3.1. Overview of Uveitis
3.2. Uveitis SWOT Analysis
3.3. Progression of Uveitis
3.4. Diagnosis and Classification of Uveitis
4. Epidemiology
4.1. Diagnosed Incident Cases of Uveitis
4.2. Diagnosed Prevalent Cases of Uveitis
4.3. Age-Specific Trends in Diagnosed Prevalent Cases of Uveitis
4.4. Sex-Specific Diagnosed Prevalent Cases of Uveitis
4.5. Diagnosed Prevalent Cases od Uveitis by Etiology, Anatomical Site of Inflammation, and Severity
4.6. Sources and Methodology for Diagnosed Incident Cases of Uveitis
4.7. Sources and Methodology for Diagnosed Prevalent Cases of Uveitis
4.8. Sources and Methodology for Diagnosed Prevalent Cases of Uveitis by Anatomical Site of Inflammation
4.9. Sources and Methodology for Diagnosed Prevalent Cases of Uveitis by Etiology
4.10. Sources and Methodology for Diagnosed Prevalent Cases of Uveitis by Severity
4.11. Sources and Methodology - Diagnosed Incident and Prevalent Cases of Uveitis
4.12. Sources and Methodology - Diagnosed Prevalent Cases of Uveitis by Anatomical Site
5. Current Treatment Options
5.1. Treatment Paradigm
5.2. Current Treatment Options
5.3. Current Treatment Options: Key Opinion Leader Perspective
5.4. Product Profile: Corticosteroid Eye Drops
5.5. Product Profile: Ocular Steroid Injections
5.6. Product Profile: Intraocular Corticosteroid Implants
5.7. Product Profile: Systemic Corticosteroids
5.8. Product Profile: Mydriatic Agents
5.9. Product Profile: Antimetabolites
5.10. Product Profile: Alkylating Agents
5.11. Product Profile: Calcineurin Inhibitors
5.12. Product Profile: Monoclonal Antibodies
5.13. Product Profile: Adrenocorticotropic Hormone Receptor Agonists
6. Unmet Needs and Opportunities
6.1. Unmet Needs in Uveitis
6.2. Improving Safety and Side-Effect Profile
6.3. Longer-Acting Therapy/Less Frequent Dosing
6.4. Drugs with Other Mechanisms of Action
6.5. Greater Awareness and Education of Physicians/Healthcare Providers
7. R&D Strategies
7.1. Trends in Clinical Trial Design for Uveitis
7.2. Trends in Deal-Making in Uveitis
8. Pipeline Assessment
8.1. Uveitis Pipeline Overview
8.2. Late-Stage Pipeline Agents for Uveitis
8.3. Product Profile: OCS-02
8.4. Product Profile: TRS-01
8.5. Product Profile: brepocitinib tosylate
8.6. Product Profile: Baricitinib
8.7. Product Profile: KIO-104
8.8. Product Profile: EBI-031
8.9. Uveitis Clinical Trials (Phase II/III) Overview
9. Market Outlook
9.1. Uveitis Market Outlook
9.2. Uveitis Market Forecast
9.3. Market Drivers and Barriers
10. Appendix
10.1. Primary Research – KOL Information
10.2. About the Authors
11. Contact Us

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us